Squawk on the Street

Pullback After the Tech Rebound, More 737 MAX-9 Pressure On Boeing, CEOs Weigh In On Obesity Drugs 01/09/24

Jan 9, 2024
Guests on the podcast include Carl Quintanilla, Jim Cramer, and David Faber. They discuss stocks under pressure after the Nasdaq's rebound, new developments surrounding Boeing's grounded 737 MAX-9 jets, pharma CEOs' insights on the obesity drug market, Netflix downgrade, Samsung's profit miss impact, HPE's talks to acquire Juniper Networks, and Match Group's date with activism.
Ask episode
Chapters
Transcript
Episode notes